How Cannabinoids Interact With CGRP and the Neuroimmune System in Migraine | Research

The takeaway

Review explores the interplay between the endocannabinoid system and CGRP neuropeptide signaling in migraine, revealing shared neuroimmune pathways that could inform combination treatments.

Cannabinoid-CGRP crosstalk
Shared neuroimmune pathways between the endocannabinoid system and CGRP signaling in migraine pathophysiology

What the researchers found

The endocannabinoid system and CGRP signaling share neuroimmune pathways in migraine, with cannabinoids capable of modulating CGRP release and neuroinflammation.

Why it matters

Many migraine patients use cannabis alongside or instead of conventional medications. Understanding how cannabinoids affect CGRP — the key migraine peptide — is essential for informed treatment decisions and potential drug development.

The numbers in context

No specific clinical trial numbers reported — this is a mechanistic review of preclinical and translational evidence.

How the study worked

Narrative review of published literature on cannabinoid-CGRP interactions in migraine neurobiology.

Who was studied

N/A — narrative review of preclinical and translational research

What this study cannot tell us

Narrative review. Most cannabinoid-CGRP interaction data is preclinical. Clinical evidence for cannabis in migraine is limited. Cannabis composition and dosing variability make research challenging.

How to read the evidence

Preliminary evidence: narrative review of mostly preclinical data on cannabinoid-CGRP interactions.

When this study was published

Published in 2024. Timely as both CGRP drugs and medical cannabis expand for migraine.

The bigger picture

The intersection of cannabinoid and peptide neurobiology is an emerging research area. As both CGRP drugs and medical cannabis become more available for migraine, understanding their interactions becomes clinically important for avoiding adverse effects and potentially enabling synergistic treatments.

Questions still open

Could cannabinoids complement CGRP antibodies for migraine prevention?
Do patients using cannabis alongside CGRP drugs experience different outcomes?
Which cannabinoid compounds most effectively modulate CGRP release?

Common questions

Can cannabis help with migraines?

Some migraine patients report benefit from cannabis, and this review explains potential mechanisms — cannabinoids may modulate CGRP release and neuroinflammation. However, clinical evidence is limited, and cannabis can also trigger headaches in some people.

Is it safe to use cannabis with CGRP migraine drugs?

The interaction between cannabinoids and CGRP drugs is not well-studied. Since both affect overlapping neuroimmune pathways, there could be interactions. Patients should discuss cannabis use with their neurologist, especially when taking anti-CGRP medications.

Read the original research

Interplay between cannabinoids and the neuroimmune system in migraine.

The journal of headache and pain, 25(1), 178

View on PubMed ↗Publisher’s paper ↗

Citation

Zorrilla, Erik; Della Pietra, Adriana; Russo, Andrew F. (2024). Interplay between cannabinoids and the neuroimmune system in migraine.. The journal of headache and pain, 25(1), 178. https://doi.org/10.1186/s10194-024-01883-3